151
|
Rébé C, Filomenko R, Raveneau M, Chevriaux A, Ishibashi M, Lagrost L, Junien JL, Gambert P, Masson D. Identification of biological markers of liver X receptor (LXR) activation at the cell surface of human monocytes. PLoS One 2012. [PMID: 23185273 PMCID: PMC3504056 DOI: 10.1371/journal.pone.0048738] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
Background Liver X receptor (LXR) α and LXR β (NR1H3 and NR1H2) are oxysterol-activated nuclear receptors involved in the control of major metabolic pathways such as cholesterol homeostasis, lipogenesis, inflammation and innate immunity. Synthetic LXR agonists are currently under development and could find applications in various fields such as cardiovascular diseases, cancer, diabetes and neurodegenerative diseases. The clinical development of LXR agonists requires the identification of biological markers for pharmacodynamic studies. In this context, monocytes represent an attractive target to monitor LXR activation. They are easily accessible cells present in peripheral blood; they express LXR α and β and respond to LXR agonist stimulation in vitro. The aim of our study was to identify cell surface markers of LXR agonists on monocytes. For this, we focused on clusters of differentiation (CD) markers because they are well characterized and accessible cell surface molecules allowing easy immuno-phenotyping. Methodology/Principal Findings By using microarray analysis of monocytes treated or not with an LXR agonist in vitro, we selected three CD, i.e. CD82, CD226, CD244 for further analysis by real time PCR and flow cytometry. The three CD were up-regulated by LXR agonist treatment in vitro in a time- and dose- dependent manner and this induction was LXR specific as assessed by a SiRNA or LXR antagonist strategy. By using flow cytometry, we could demonstrate that the expression of these molecules at the cell surface of monocytes was significantly increased after LXR agonist treatment. Conclusions/Significance We have identified three new cell surface markers that could be useful to monitor LXR activation. Future studies will be required to confirm the biological and diagnostic significance of the markers.
Collapse
Affiliation(s)
- Cédric Rébé
- Centre de Recherche Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 866, Université de Bourgogne, Dijon, France
- Structure Fédérative de Recherche Santé-Sciences et Techniques de l'Information et de la Communication, Université de Bourgogne, Dijon, France
- Centre Georges-François Leclerc, Dijon, France
| | - Rodolphe Filomenko
- Structure Fédérative de Recherche Santé-Sciences et Techniques de l'Information et de la Communication, Université de Bourgogne, Dijon, France
| | - Magalie Raveneau
- Structure Fédérative de Recherche Santé-Sciences et Techniques de l'Information et de la Communication, Université de Bourgogne, Dijon, France
| | - Angélique Chevriaux
- Centre de Recherche Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 866, Université de Bourgogne, Dijon, France
- Structure Fédérative de Recherche Santé-Sciences et Techniques de l'Information et de la Communication, Université de Bourgogne, Dijon, France
- Centre Georges-François Leclerc, Dijon, France
| | - Minako Ishibashi
- Centre de Recherche Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 866, Université de Bourgogne, Dijon, France
- Structure Fédérative de Recherche Santé-Sciences et Techniques de l'Information et de la Communication, Université de Bourgogne, Dijon, France
| | - Laurent Lagrost
- Centre de Recherche Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 866, Université de Bourgogne, Dijon, France
- Structure Fédérative de Recherche Santé-Sciences et Techniques de l'Information et de la Communication, Université de Bourgogne, Dijon, France
- Centre Hospitalier Universitaire Dijon, Dijon, France
| | - Jean Louis Junien
- Structure Fédérative de Recherche Santé-Sciences et Techniques de l'Information et de la Communication, Université de Bourgogne, Dijon, France
| | - Philippe Gambert
- Centre de Recherche Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 866, Université de Bourgogne, Dijon, France
- Structure Fédérative de Recherche Santé-Sciences et Techniques de l'Information et de la Communication, Université de Bourgogne, Dijon, France
- Centre Hospitalier Universitaire Dijon, Dijon, France
| | - David Masson
- Centre de Recherche Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 866, Université de Bourgogne, Dijon, France
- Structure Fédérative de Recherche Santé-Sciences et Techniques de l'Information et de la Communication, Université de Bourgogne, Dijon, France
- Centre Hospitalier Universitaire Dijon, Dijon, France
- * E-mail:
| |
Collapse
|
152
|
Rahman SM, Choudhury M, Janssen RC, Baquero KC, Miyazaki M, Friedman JE. CCAAT/enhancer binding protein β deletion increases mitochondrial function and protects mice from LXR-induced hepatic steatosis. Biochem Biophys Res Commun 2012; 430:336-9. [PMID: 23159614 DOI: 10.1016/j.bbrc.2012.11.027] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2012] [Accepted: 11/02/2012] [Indexed: 12/13/2022]
Abstract
Drugs designed specifically to activate liver X receptors (LXRs) have beneficial effects on lowering cholesterol metabolism and inflammation but unfortunately lead to severe hepatic steatosis. The transcription factor CCAAT/enhancer binding protein beta (C/EBPβ) is an important regulator of liver gene expression but little is known about its involvement in LXR-based steatosis and cholesterol metabolism. The present study investigated the role of C/EBPβ expression in LXR agonist (T0901317)-mediated alteration of hepatic triglyceride (TG) and lipogenesis in mice. C/EBPβ deletion in mice prevented LXR agonist-mediated induction of lipogenic gene expression in liver in conjunction with significant reduction of liver TG accumulation. Surprisingly, C/EBPβ(-/-) mice showed a major increase in liver mitochondrial electron chain function compared to WT mice. Furthermore, LXR activation in C/EBPβ(-/-) mice increased the expression of liver ATP-binding cassette transporter ABCG1, a gene implicated in cholesterol efflux and reducing blood levels of total and LDL-cholesterol. Together, these findings establish a central role for C/EBPβ in the LXR-mediated steatosis and mitochondrial function, without impairing the influence of LXR activation on lowering LDL and increasing HDL-cholesterol. Inactivation of C/EBPβ might therefore be an important therapeutic strategy to prevent LXR activation-mediated adverse effects on liver TG metabolism without disrupting its beneficial effects on cholesterol metabolism.
Collapse
Affiliation(s)
- Shaikh M Rahman
- Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA.
| | | | | | | | | | | |
Collapse
|
153
|
Ducheix S, Podechard N, Lasserre F, Polizzi A, Pommier A, Murzilli S, Di Lisio C, D'Amore S, Bertrand-Michel J, Montagner A, Pineau T, Loiseau N, Lobaccaro JM, Martin PGP, Guillou H. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα. Biochimie 2012; 95:556-67. [PMID: 23063693 DOI: 10.1016/j.biochi.2012.09.028] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2012] [Accepted: 09/24/2012] [Indexed: 01/23/2023]
Abstract
The Liver X Receptors (LXRs) α and β and the Peroxisome Proliferator-Activated Receptor α (PPARα) are transcription factors that belong to class II nuclear receptors. They drive the expression of genes involved in hepatic lipid homeostasis and therefore are important targets for the prevention and treatment of nonalcoholic fatty liver disease (NAFLD). LXRs and PPARα are regulated by endogenous ligands, oxysterols and fatty acid derived molecules, respectively. In the liver, pharmacological activation of LXRs leads to the over-expression of genes involved in de novo lipogenesis, while PPARα is critical for fatty acid catabolism in nutrient deprivation. Even if these two nuclear receptors seemed to play opposite parts, recent studies have highlighted that PPARα also influence the expression of genes involved in fatty acids synthesis. In this study, we used pharmacological approaches and genetically engineered mice to investigate the cross-talk between LXRs and PPARα in the regulation of genes responsible for lipogenesis. We first investigated the effect of T0901317 and fenofibrate, two synthetic agonists of LXRs and PPARα, respectively. As expected, T0901317 and fenofibrate induce expression of genes involved LXR-dependent and PPARα-dependent lipogenic responses. Considering such overlapping effect, we then tested whether LXR agonist may influence PPARα driven response and vice versa. We show that the lack of PPARα does not influence the effects of T0901317 on lipogenic genes expression. However, PPARα deficiency prevents the up-regulation of genes involved in ω-hydroxylation that are induced by the LXR agonist. In addition, over-expression of lipogenic genes in response to fenofibrate is decreased in LXR knockout mice as well as the expression of PPARα target genes involved in fatty acid oxidation. Altogether, our work provides in vivo evidence for a central interconnection between nuclear receptors that drive hepatic lipid metabolism in response to oxysterol and fatty acids.
Collapse
Affiliation(s)
- Simon Ducheix
- INRA, UMR1331, Toxalim, Research Centre in Food Toxicology, Université de Toulouse, Toulouse, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|